|
41 |
Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma
Adeberg, Sebastian. - London : BioMed Central, 2016
|
|
|
|
42 |
Prognostic relevance of miRNA-155 methylation in anaplastic glioma
Schließer, Maximilian Georg. - Augsburg : Universität Augsburg, 2016
|
|
|
|
43 |
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial - study protocol
Diem, Ricarda. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
|
|
|
|
44 |
Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion
Nylandsted, Jesper. - Konstanz : Bibliothek der Universität Konstanz, 2009
|
|
|
45 |
1H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy
Enthalten in Orphanet journal of rare diseases Bd. 16, 20.10.2021, Nr. 1, date:12.2021: 1-16
|
|
|
|
46 |
A H3K27M-targeted vaccine in adults with diffuse midline glioma
Enthalten in Nature medicine Bd. 29, 21.9.2023, Nr. 10, date:10.2023: 2586-2592
|
|
|
|
47 |
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Enthalten in Journal of neuro-oncology Bd. 146, 27.11.2019, Nr. 1, date:1.2020: 79-89
|
|
|
|
48 |
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
Enthalten in Neurological research and practice Bd. 4, 23.5.2022, Nr. 1, date:12.2022: 1-7
|
|
|
|
49 |
Brain Tumor Networks in Diffuse Glioma
Enthalten in Neurotherapeutics Bd. 19, 10.11.2022, Nr. 6, date:10.2022: 1832-1843
|
|
|
|
50 |
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
Enthalten in Acta neuropathologica Bd. 140, 8.7.2020, Nr. 3, date:9.2020: 409-413
|
|
Administration
